Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S.
Go back to Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S.| VolitionRX Limited (NYSE: VNRX) | Delayed: 0.47 -0.03 (6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $5.86 | |||
| Open | $0.51 | 52 Week Low | $3.05 | |||
| Day High | $0.53 | P/E | N/A | |||
| Day Low | $0.47 | EPS | $-0.45 | |||
| Volume | 540,335 | |||||
